Literature DB >> 23352111

Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B.

Stefanie Koristka1, Marc Cartellieri, Claudia Arndt, Claudia C Bippes, Anja Feldmann, Irene Michalk, Kristin Wiefel, Slava Stamova, Marc Schmitz, Gerhard Ehninger, Martin Bornhäuser, Michael Bachmann.   

Abstract

The nuclear autoantigen La can be detected on the surface of dying cells. Here we present an assay which enables us to show that La protein is not limited to the surface of dying cells but will be released upon stress-induced cell death. As released La protein tightly binds to the surface of neighboring intact cells we asked the question whether or not La protein could serve as a stress-inducible target e.g. for redirecting of regulatory T cells (Tregs) into damaged tissues to downregulate an immune response. In order to provide first proof of concept we developed a novel fully humanized single-chain bispecific antibody (bsAb) which on the one hand is directed to the La antigen and on the other hand to the CD3 complex of T cells. A cross-linkage of Tregs with La-decorated target cells mediated by this bsAb resulted indeed in the activation of the Tregs in a target-dependent manner. Moreover, such bsAb activated Tregs displayed a potent suppressive capacity and negatively influenced proliferation, expansion and cytokine production of autologous CD4(+) and CD8(+) Teff cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23352111     DOI: 10.1016/j.jaut.2013.01.002

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  32 in total

1.  The challenge of treating orphan disease.

Authors:  Carlos Dias; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

2.  A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform.

Authors:  Susann Albert; Claudia Arndt; Anja Feldmann; Ralf Bergmann; Dominik Bachmann; Stefanie Koristka; Florian Ludwig; Pauline Ziller-Walter; Alexandra Kegler; Sebastian Gärtner; Marc Schmitz; Armin Ehninger; Marc Cartellieri; Gerhard Ehninger; Hans-Jürgen Pietzsch; Jens Pietzsch; Jörg Steinbach; Michael Bachmann
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

3.  Costimulation improves the killing capability of T cells redirected to tumor cells expressing low levels of CD33: description of a novel modular targeting system.

Authors:  C Arndt; A Feldmann; M von Bonin; M Cartellieri; E-M Ewen; S Koristka; I Michalk; S Stamova; N Berndt; A Gocht; M Bornhäuser; G Ehninger; M Schmitz; M Bachmann
Journal:  Leukemia       Date:  2013-08-20       Impact factor: 11.528

Review 4.  Bispecific antibodies and CARs: generalized immunotherapeutics harnessing T cell redirection.

Authors:  Eugene A Zhukovsky; Richard J Morse; Marcela V Maus
Journal:  Curr Opin Immunol       Date:  2016-03-08       Impact factor: 7.486

5.  Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management.

Authors:  Claudia Arndt; Ralf Bergmann; Franziska Striese; Keresztély Merkel; Domokos Máthé; Liliana R Loureiro; Nicola Mitwasi; Alexandra Kegler; Frederick Fasslrinner; Karla Elizabeth González Soto; Christin Neuber; Nicole Berndt; Noemi Kovács; David Szöllősi; Nikolett Hegedűs; Gyula Tóth; Jan-Philipp Emmermann; Kuzhuvelil B Harikumar; Tibor Kovacs; Michael Bachmann; Anja Feldmann
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

6.  Characterization of a novel single-chain bispecific antibody for retargeting of T cells to tumor cells via the TCR co-receptor CD8.

Authors:  Irene Michalk; Anja Feldmann; Stefanie Koristka; Claudia Arndt; Marc Cartellieri; Armin Ehninger; Gerhard Ehninger; Michael P Bachmann
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

7.  Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane binding.

Authors:  Francesca Gugliesi; Mandar Bawadekar; Marco De Andrea; Valentina Dell'Oste; Valeria Caneparo; Angela Tincani; Marisa Gariglio; Santo Landolfo
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

8.  Bispecific antibody releasing-mesenchymal stromal cell machinery for retargeting T cells towards acute myeloid leukemia blasts.

Authors:  R Aliperta; M Cartellieri; A Feldmann; C Arndt; S Koristka; I Michalk; M von Bonin; A Ehninger; J Bachmann; G Ehninger; M Bornhäuser; M P Bachmann
Journal:  Blood Cancer J       Date:  2015-09-18       Impact factor: 11.037

9.  TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunity.

Authors:  Marc Cartellieri; Claudia Arndt; Anja Feldmann; Malte von Bonin; Eva-Maria Ewen; Stefanie Koristka; Irene Michalk; Slava Stamova; Nicole Berndt; Anne Gocht; Martin Bornhäuser; Gerhard Ehninger; Marc Schmitz; Michael Bachmann
Journal:  Oncoimmunology       Date:  2013-10-22       Impact factor: 8.110

10.  A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells.

Authors:  Marc Cartellieri; Stefanie Koristka; Claudia Arndt; Anja Feldmann; Slava Stamova; Malte von Bonin; Katrin Töpfer; Thomas Krüger; Mathias Geib; Irene Michalk; Achim Temme; Martin Bornhäuser; Dirk Lindemann; Gerhard Ehninger; Michael P Bachmann
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.